Dermatological alterations induced by gynecological hormonal imbalances: Acne, hirsutism and alopecia

Sex hormones play a fundamental role in regulating skin physiology, influencing collagen synthesis, wound healing, immune modulation, and barrier function. Estrogens and progesterone, through their respective receptors, modulate gene expression in cutaneous structures. Hormonal fluctuations throughout the female lifespan such as those occurring during puberty, pregnancy, and menopause affect dermatological conditions including psoriasis, xerosis, and age-related thinning. Disorders characterized by androgen excess, particularly polycystic ovary syndrome, are strongly associated with acne, excessive terminal hair growth, and hormonally mediated hair loss. In these cases, elevated androgen levels and insulin resistance act synergistically to worsen clinical manifestations. Other endocrine disorders, such as non-classic congenital adrenal hyperplasia and estrogen deficiency during menopause, also contribute to cutaneous alterations.Hormonal acne, often concentrated in the lower facial region, is linked to elevated androgens and requires targeted therapies such as combined hormonal contraceptives, antiandrogenic medications like spironolactone, or isotretinoin in resistant cases. Excessive terminal hair growth is evaluated using standardized scoring systems and treated with hormonal therapies and cosmetic procedures. Hormonal hair loss includes female pattern hair thinning and telogen effluvium, the latter often triggered by estrogen withdrawal or thyroid dysfunction. Diagnosis includes trichoscopy and comprehensive hormonal profiling.Key hormonal tests such as total and free testosterone, dehydroepiandrosterone sulfate, seventeen-hydroxyprogesterone, thyroid-stimulating hormone, prolactin, and the luteinizing hormone to follicle-stimulating hormone ratio aid in identifying endocrine dysfunction. A multidisciplinary approach that integrates dermatological, gynecological, and endocrine care is essential. Given the significant psychological burden of these conditions, holistic strategies that incorporate mental health support are necessary to improve both physical and emotional outcomes.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-10-31
DOI
https://doi.org/10.5281/zenodo.17558367
Primary Topic
Hair Growth and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dermatological alterations induced by gynecological hormonal imbalances: Acne, hirsutism and alopecia

Zenodo (CERN European Organization for Nuclear Research)
Hair Growth and Disorders
article

Dermatological alterations induced by gynecological hormonal imbalances: Acne, hirsutism and alopecia

article en

Abstract

Sex hormones play a fundamental role in regulating skin physiology, influencing collagen synthesis, wound healing, immune modulation, and barrier function. Estrogens and progesterone, through their respective receptors, modulate gene expression in cutaneous structures. Hormonal fluctuations throughout the female lifespan such as those occurring during puberty, pregnancy, and menopause affect dermatological conditions including psoriasis, xerosis, and age-related thinning. Disorders characterized by androgen excess, particularly polycystic ovary syndrome, are strongly associated with acne, excessive terminal hair growth, and hormonally mediated hair loss. In these cases, elevated androgen levels and insulin resistance act synergistically to worsen clinical manifestations. Other endocrine disorders, such as non-classic congenital adrenal hyperplasia and estrogen deficiency during menopause, also contribute to cutaneous alterations.Hormonal acne, often concentrated in the lower facial region, is linked to elevated androgens and requires targeted therapies such as combined hormonal contraceptives, antiandrogenic medications like spironolactone, or isotretinoin in resistant cases. Excessive terminal hair growth is evaluated using standardized scoring systems and treated with hormonal therapies and cosmetic procedures. Hormonal hair loss includes female pattern hair thinning and telogen effluvium, the latter often triggered by estrogen withdrawal or thyroid dysfunction. Diagnosis includes trichoscopy and comprehensive hormonal profiling.Key hormonal tests such as total and free testosterone, dehydroepiandrosterone sulfate, seventeen-hydroxyprogesterone, thyroid-stimulating hormone, prolactin, and the luteinizing hormone to follicle-stimulating hormone ratio aid in identifying endocrine dysfunction. A multidisciplinary approach that integrates dermatological, gynecological, and endocrine care is essential. Given the significant psychological burden of these conditions, holistic strategies that incorporate mental health support are necessary to improve both physical and emotional outcomes.

Zenodo (CERN European Organization for Nuclear Research)
Earth University (CR), Costa Rican Department of Social Security (CR), Poder Judicial de la Ciudad de Buenos Aires (AR), Universidad Independiente (CR)
Good health and well-being
Openalex Percentile: Top 33%
Hair Growth and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.